Albuterol syrup pharmacology

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Albuterol Syrup Pharmacology: Mechanism, Efficacy, and Pharmacokinetics

Beta-2 Adrenergic Agonist Mechanism of Action

Albuterol syrup is a selective beta-2 adrenergic receptor agonist. It works by relaxing the smooth muscles in the airways, leading to bronchodilation and relief from bronchospasm, which is especially useful in asthma management 34.

Pharmacokinetics and Bioavailability of Albuterol Syrup

Albuterol syrup is rapidly absorbed after oral administration. Peak plasma concentrations are typically reached within 1.8 to 2 hours, and the drug has an elimination half-life of about 4.8 to 5.5 hours. The bioavailability of albuterol syrup is equivalent to that of tablet formulations, meaning both forms deliver similar amounts of active drug into the bloodstream 34. The duration of action for albuterol syrup is at least 6 to 8 hours, making it effective for sustained bronchodilation 14.

Clinical Efficacy in Asthma

In children with mild to moderate asthma, albuterol syrup provides significant improvement in pulmonary function. It produces a greater peak magnitude of bronchodilation compared to metaproterenol syrup and maintains this effect for at least 8 hours. Albuterol syrup also leads to higher morning and evening peak flow measurements, indicating better overall asthma control . When compared to tablet formulations, albuterol syrup offers a longer duration of bronchodilation and is more effective in reducing the need for additional rescue medications .

Side Effects and Safety Profile

The side effects of albuterol syrup are generally mild and comparable to those of other oral beta-2 agonists. Common side effects include mild increases in heart rate and occasional tremor. The syrup formulation may cause slightly greater increases in heart rate compared to tablets, but these effects are usually not clinically significant 134. Overall, albuterol syrup is well tolerated in children.

Influence of Genetic Polymorphisms

The response to albuterol syrup can vary based on genetic differences in the beta-2 adrenergic receptor. Individuals with certain genetic variants (such as Arg16 homozygotes) experience a greater and more rapid bronchodilator response compared to those with other variants (like Gly16 carriers). This suggests that genetic testing may help predict individual responses to albuterol therapy in the future .

Conclusion

Albuterol syrup is a fast-acting, effective, and well-tolerated oral bronchodilator for asthma, especially in children. It offers similar bioavailability to tablet forms but may provide longer-lasting bronchodilation and better symptom control. Genetic factors can influence individual responses, highlighting the potential for personalized asthma therapy in the future.

Sources and full results

Most relevant research papers on this topic

Comparison of albuterol and metaproterenol syrup in the treatment of childhood asthma.

Albuterol syrup has therapeutic advantages over metaproterenol syrup in improving pulmonary function, chronotropic effects, and frequency of dosing in children with mild to moderate asthma.

Non-RCT

1991·

11citations

·J. Wolfe et al.

Pediatrics·

DOI

Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma.

Both tablet and syrup formulations of procaterol hydrochloride are equivalent in bronchodilating efficacy and safety for childhood asthma.

Non-RCT

1985·

3citations

·J. Kemp et al.

Annals of allergy

Comparative bioavailability and pharmacokinetics of three formulations of albuterol.

The bioavailability of albuterol from tablet and solution formulations is equivalent, with rapid absorption and comparable maximum drug concentrations.

RCT

1985·

37citations

·M. Powell et al.

Journal of pharmaceutical sciences·

DOI

Oral albuterol in the treatment of childhood asthma.

Four milligrams of albuterol syrup (2 mg/5 ml) four times a day is the preferred dose for asthmatic children aged 6 to 14 years, with syrup providing longer-lasting relief and greater heart rate changes.

RCT

1982·

16citations

·G. Rachelefsky et al.

Pediatrics·

DOI

Impact of genetic polymorphisms of the β2‐adrenergic receptor on albuterol bronchodilator pharmacodynamics

The 2-adrenergic receptor gene polymorphism significantly affects bronchodilator response to albuterol in patients with moderate asthma.

Non-RCTHighly Cited

1999·

262citations

·J. Lima et al.

Clinical Pharmacology & Therapeutics·

DOI

Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans

The eutomer of albuterol is more potent than the distomer, but its bioavailability is less than racemate, and its metabolism is more efficient without the distomer.

Non-RCT

1997·

53citations

·D. Boulton et al.

Clinical Pharmacology & Therapeutics·

DOI

Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle.

Active (R)-albuterol is more abundantly distributed in skeletal and cardiac muscle compared to inactive (S)-albuterol, impacting sports doping, cardiac effects, and therapeutic use in muscle wasting diseases.

Non-RCTAnimal Study

2014·

21citations

·G. Jacobson et al.

Drug testing and analysis·

DOI

Albuterol syrup in the treatment of the young asthmatic child.

Albuterol syrup is effective and safe for treating young asthmatic children, reducing symptom scores and need for additional medications without significant side effects.

RCT

1981·

14citations

·G. Rachelefsky et al.

Annals of allergy

The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study.

Inhaled albuterol reduces lower esophageal sphincter basal tone and contractile amplitudes in a dose-dependent manner, potentially increasing acid reflux in patients receiving cumulative dosing.

RCT

2001·

60citations

·M. Crowell et al.

Chest

Albuterol: An Adrenergic Agent for Use in the Treatment of Asthma Pharmacology, Pharmacokinetics and Clinical Use

Albuterol is an effective and safe treatment for acute asthma, with aerosolized inhalation being the best option for first-line management.

Highly Cited

1984·

82citations

·R. Ahrens et al.

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy·

DOI

Try another search

sputnik 1 historical significance

law of conservation of matter

foods that reduce stomach acidity

vitamin supplementation for depression and anxiety

Feminist theory in contemporary literature

space phenomena